SINGAPORE, SG / ACCESS Newswire / January 12, 2026 / Following its acquisition of ADK Global last year, Assembly today announced the …
© Irani Updates | All Rights Reserved
Latest in ACCESS Newswire
-
-
ACCESS Newswire
Datavault AI Announces Target to Expand its AI Driven Data Monetization Network to Over 100 Cities Across the Contiguous United States, Starting in the Second Half of 2026 with Corresponding 2027 Revenue Target
Datavault AI expects to have a fully operational network with over 100 nodes across 33 cities nationwide, generating revenue in the second …
-
MIAMI, FL / ACCESS Newswire / January 9, 2026 / PromiCell, Inc. (the “Company”), a clinical-stage cellular immunotherapy company uniquely positioned to …
-
Ending the Year on a High Note SOLANA BEACH, CA / ACCESS Newswire / December 16, 2025 / American Wave Machines, the …
-
MIAMI, FLORIDA / ACCESS Newswire / December 16, 2025 / AstraZeneca, Eastman, Kraft Heinz, and P&G have been recognized for their outstanding …
-
ACCESS Newswire
All Scientific Mechanisms Verified: Why Asia Can Now Treat Neutrinovoltaics as Hard Physics
The scientific chain behind Neutrino® Energy Group‘s neutrinovoltaic technology, once debated, now stands independently confirmed. BERLIN, DE / ACCESS Newswire / December …
-
ACCESS Newswire
All Scientific Mechanisms Verified: Why Asia Can Now Treat Neutrinovoltaics as Hard Physics
The scientific chain behind Neutrino® Energy Group‘s neutrinovoltaic technology, once debated, now stands independently confirmed. BERLIN, DE / ACCESS Newswire / December …
-
ACCESS Newswire
The 13th GLA Global Logistics Conference Successfully Concludes in Bangkok, Thailand
More than 2,000 logistics leaders from 130+ countries convene in Thailand to advance peace, digital innovation and trustworthy cooperation in global supply …
-
ACCESS Newswire
Oman’s 10-Year Golden Residency Program Attracts Global Investors Seeking Stability and Long-Term Access
Built for investors who value certainty, global access, and long-term confidence. MUSCAT, OM / ACCESS Newswire / December 3, 2025 / Three …
-
ACCESS Newswire
GEN Announces New Positive Phase 1 Trial Data of the Investigational Drug SUL-238 for Alzheimer’s and Other Neurodegenerative Diseases
Phase 1 results show that SUL-238 is safe, well-tolerated, and demonstrates favorable pharmacokinetics with high CSF penetration in healthy elderly volunteers, supporting …